ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim…
Data Shows ReShape’s DBSN™ System has Promise as a Novel, Adjustable and Localized Approach to Treat Type 2 Diabetes SAN CLEMENTE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- ReShape…